Susquehanna International Group
OCDX

Susquehanna International Group’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Susquehanna International Group’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-24,100
Closed -$450K – 14535
2022
Q1 		$450K Buy
24,100
+14,700
+156% +$265K ﹤0.01% 9247
2021
Q4 		$201K Buy
+9,400
New +$185K ﹤0.01% 11445
2021
Q3 		– Sell
-94,700
Closed -$2.03M – 13952
2021
Q2 		$2.03M Buy
94,700
+15,600
+20% +$317K ﹤0.01% 5888
2021
Q1 		$1.53M Buy
+79,100
New +$1.39M ﹤0.01% 6596

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Susquehanna International Group's OCDX Position: Q2 2022 in Review

Susquehanna International Group sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 46,519 shares — an estimated $868K sold.

Susquehanna International Group first reported a position in OCDX in Q3 2021 and held it in 3 quarters. The position peaked at $1.52M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Susquehanna International Group reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Susquehanna International Group sold 46,519 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $868K.
  • Susquehanna International Group first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q3 2021 and held it in 3 quarters.
  • Susquehanna International Group's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $1.52M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Susquehanna International Group's 13F filing for Q2 2022, filed 15 Aug 2022.